BioSight Company
Innovative Cancer Targeted Pro-Drugs.
Technology:
Small Molecules
Industry:
Geroscience
Headquarters:
Carmiel, HaZafon, Israel
Founded Date:
2000-01-01
Employees Number:
1-10
Funding Status:
Late Stage Venture
Investors Number:
9
Total Funding:
59000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-12-02
Last Funding Type:
Series C
Register and Claim Ownership